Search

Your search keyword '"Féry, F."' showing total 96 results

Search Constraints

Start Over You searched for: Author "Féry, F." Remove constraint Author: "Féry, F."
96 results on '"Féry, F."'

Search Results

1. Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung

4. TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt/β-catenin signaling

5. Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung

7. Blood CD9+B cell, a biomarker of bronchiolitis obliterans syndrome after lung transplantation

8. Genotype-phenotype relations in diabetic patients diagnosed in early adulthood

9. Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

10. Increased prevalence of abnormal immunoglobulin M, G, and A concentrations at clinical onset of insulin-dependent diabetes mellitus: a registry-based study. The Belgian Diabetes Registry

13. T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase‐9 via a C‐C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction

15. Effect of short term fasting on glucose tolerance and insulin secretion: influence of the initial glucose level

26. 35th Annual Meeting of the European Association for the Study of Diabetes

30. Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients

31. Lean non-alcoholic fatty liver disease (Lean-NAFLD): A major cause of cryptogenic liver disease

34. OGTT is recommended for glucose homeostasis assessments in Friedreich ataxia.

35. Beneficial Outcomes of Sleeve Gastrectomy in a Morbidly Obese Patient With Bardet-Biedl Syndrome.

36. [New oral antidiabetic drugs].

37. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.

38. [Screening strategy and diagnostic criteria for gestational diabetes. Proposals of the GGOLFB].

39. Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.

40. [The incretin effect: a new therapeutic target in type 2 diabetes].

41. Effect of somatostatin on duodenal glucose absorption in man.

42. [Etiopathogenesis and pathophysiology of type 2 diabetes].

43. Comparison of intraduodenal and intravenous glucose metabolism under clamp conditions in humans.

44. Identification and functional assessment of novel and known insulin receptor mutations in five patients with syndromes of severe insulin resistance.

45. Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood.

46. [The endocrinology department].

47. Metabolic handling of intraduodenal vs. intravenous glucose in humans.

48. [Role of diet in the treatment of diabetes].

49. [New treatments for obesity].

Catalog

Books, media, physical & digital resources